Browsing by Author Conry, Robert

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2006Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group.Millward, Michael; Bedikian, Agop Y.; Conry, Robert; DeConti, Ronald; Gore, Martin; Haluska, Frank G.; Hersey, Peter; Hersh, Evan M.; Kirkwood, John M; Pavlick, Anna C.; Pehamberger, Hubert; Trefzer, Uwe; MedicineBcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group., JOURNAL OF CLINICAL ONCOLOGY 2005, vol.24,(29),2006,pp 4738-4745
2015A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanomaKefford, Richard (Rick); Agarwala, Sanjiv; Bhatia, S.; Brachmann, C.; Brown, Michael P.; Clawson, A.; Conry, Robert; Del Vecchio, M.; Elias, I.; Ernst, S.; Grob, Jean Jacques; Gutzmer, R.; Hauschild, A; Haydon, A.; Hersh, Evan M.; Homsi, J.; Karnoub, M; Kendra, K.; Li, M.; Loquai, C.; Rebscgler, M. F.; Robert, Caroline; Testori, Alessandro; Western Clinical School: Westmead Institute for Medical ResA randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma, Annals of Oncology, vol.26, 11, 2015,pp 2267-2274